✦ LIBER ✦

Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101

✍ Scribed by Sonke Svenson; Marc Wolfgang; Jungyeon Hwang; John Ryan; Scott Eliasof

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

423 Phase 1 dose escalation, safety and

✍ Y. Yen; T. Synold; G.J. Weiss; T. Schluep; J. Ryan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Novel compounds in preclinical/early cli

✍ Erik De Clercq 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 1 views

Preclinical and early clinical studies o

✍ Lavrovsky, Yan; Ivachtchenko, Alexander V.; Morozova, M.; Salimov, R.M.; Kasey, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Preclinical and Clinical Development of

✍ Maria Serova; Aïda Ghoul; Karim A. Benhadji; Esteban Cvitkovic; Sandrine Faivre; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Comparative efficacy and safety of the n

✍ Ufer, M. 📂 Article 📅 2010 🏛 Schattauer 🌐 English ⚖ 326 KB

Necitumumab in the treatment of advanced

✍ Dienstmann, Rodrigo; Felip, Enriqueta 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 242 KB